A patient with genetically confirmed myoclonus-dystonia responded to anticholinergic treatment and improved spontaneously

Author(s): Lee JH, Lyoo CH, Lee MS

Abstract

Background:The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission.

Case report:A 19-year-old girl presented with a 14-year history of myoclonus and dystonia that severely affected her left arm, neck, and trunk. Genetic studies showed a mutation in SGCE [deletion in exon 6 (c.771_772delAT, Cys258X)]. Both myoclonus and dystonia responded to anticholinergic treatment for 7 years and improved spontaneously.

Conclusions:The possibility of spontaneous improvement should be kept in mind when considering the therapeutic strategy in myoclonus-dystonia patients, especially when contemplating deep-brain stimulation.

Similar Articles

Myoclonus-dystonia syndrome

Author(s): Nardocci N

Myoclonus-dystonia, obsessive-compulsive disorder, and alcohol dependence in SGCE mutation carriers

Author(s): Hess CW, Raymond D, AguiarPde C, Frucht S, Shriberg J, et al.

A novel locus for inherited myoclonus-dystonia on 18p11

Author(s): Grimes DA, Han F, Lang AE, St George-Hyssop P, Racacho L, et al.

Association of a missense change in the D2 dopamine receptor with myoclonus dystonia

Author(s): Klein C, Brin MF, Kramer P, Sena-Esteves M, de Leon D, et al.

Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: evidence for genetic heterogeneity

Author(s): Valente EM, Misbahuddin A, Brancati F, Placzek MR, Garavaglia B, et al.

The diversity of GABAA receptors

Author(s): Hevers W, Lüddens H

[Why benzodiazepines are still in wide use?]

Author(s): Vlastelica M, Jelaska M

Myoclonus-dystonia syndrome due to tyrosine hydroxylase deficiency

Author(s): Stamelou M, Mencacci NE, Cordivari C, Batla A, Wood NW, et al.

Biochemical hallmarks of tyrosine hydroxylase deficiency

Author(s): Bräutigam C, Wevers RA, Jansen RJ, Smeitink JA, de Rijk-van Andel JF, et al.

Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia

Author(s): Hoffmann GF, Assmann B, Bräutigam C, Dionisi-Vici C, Häussler M, et al.

Surgical treatment of myoclonus dystonia syndrome

Author(s): Rughani AI, Lozano AM